Avanos Medical, Inc. (AVNS) Reports In-Line Q1 EPS

Avanos Medical, Inc. (NYSE: AVNS) reported Q1 EPS of $0.26, in-line with the analyst estimate of $0.26. Revenue for the quarter came in at $197 million versus the consensus estimate of $197.8 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2022 EPS of $1.55-$1.75, versus the consensus of $1.64.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)
• Jefferies Starts Oversea-Chinese Banking Corp Ltd (OCBC:SP) (OVCHF) at Hold